Nucleus Network's Brisbane facility (originally Q-Pharm) is a dedicated 65-bed clinical trial unit located at the Royal Brisbane and Women’s Hospital. Australia's second largest Phase 1 unit (second only to Nucleus Network Melbourne), the Brisbane unit undertakes clinical trials for companies and researchers who are developing new, safer or more effective medicines. The benefits of conducting clinical trials at Q-Pharm are: - Reliable and extensive experience over 15 years with 400+ Early Phase studies successfully completed and 15000+ participants recruited - Fast clinical trial start-up (~4-6 weeks from ethics submission to commencement of the clinical trial) - Frequent dates for ethics submission (40 meetings per year total - local & commercial committee options) - Clinical trials are completed on time and within budget - Excellent working relationship with local HREC (submitted, managed and conducted > 400 studies) and commercial HREC (multiple submissions approved in single round of review) - USA (FDA), Europe (AFSSAPS and AEMPS), and South America (ANVISA) inspected - Data accepted worldwide by regulators - Safe location (high level of IP protection, low-risk stable destination)